scholarly article | Q13442814 |
P356 | DOI | 10.2217/14622416.7.2.177 |
P698 | PubMed publication ID | 16515397 |
P2093 | author name string | Yi Yang | |
Jeffrey F Waring | |||
Rita Ciurlionis | |||
Stephen J Abel | |||
P2860 | cites work | Summaries of Affymetrix GeneChip probe level data | Q27860888 |
Activation of PPARalpha and PPARgamma by environmental phthalate monoesters | Q28179002 | ||
Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals | Q28204565 | ||
Clustering of hepatotoxins based on mechanism of toxicity using gene expression profiles | Q28213099 | ||
Molecular cloning of the peroxisome proliferator-induced 46-kDa cytosolic acyl-CoA thioesterase from mouse and rat liver--recombinant expression in Escherichia coli, tissue expression, and nutritional regulation | Q28579822 | ||
Can the pharmaceutical industry reduce attrition rates? | Q29616077 | ||
Platform influence on DNA microarray data in postmortem brain research | Q30984419 | ||
Differential gene regulation in human versus rodent hepatocytes by peroxisome proliferator-activated receptor (PPAR) alpha. PPAR alpha fails to induce peroxisome proliferation-associated genes in human cells independently of the level of receptor ex | Q33952364 | ||
Toxicogenomics in drug discovery: from preclinical studies to clinical trials | Q35937248 | ||
Agonist and chemopreventative ligands induce differential transcriptional cofactor recruitment by aryl hydrocarbon receptor | Q36139135 | ||
Induction of the acyl-coenzyme A synthetase gene by fibrates and fatty acids is mediated by a peroxisome proliferator response element in the C promoter | Q38292537 | ||
A gene expression signature for oxidant stress/reactive metabolites in rat liver | Q38335137 | ||
Identification of novel TCDD-regulated genes by microarray analysis. | Q40466550 | ||
Toxicogenomics-based discrimination of toxic mechanism in HepG2 human hepatoma cells | Q40736468 | ||
Predicting human safety: screening and computational approaches | Q40744635 | ||
Signal transduction-mediated activation of the aryl hydrocarbon receptor in rat hepatoma H4IIE cells | Q41066706 | ||
Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs | Q42551374 | ||
Molecular cloning and expression of cDNA encoding rat brain cytosolic acyl-coenzyme A thioester hydrolase | Q42630082 | ||
Microarray analysis of hepatotoxins in vitro reveals a correlation between gene expression profiles and mechanisms of toxicity | Q43588948 | ||
Assessment of hepatocytes and liver slices as in vitro test systems to predict in vivo gene expression | Q44495563 | ||
Effects of peroxisome proliferator-activated receptor alpha activation on pathways contributing to cholesterol homeostasis in rat hepatocytes. | Q44967119 | ||
Real-time TaqMan PCR as a specific and more sensitive alternative to the branched-chain DNA assay for quantitation of simian immunodeficiency virus RNA. | Q45738726 | ||
P433 | issue | 2 | |
P921 | main subject | toxicogenomics | Q841450 |
P304 | page(s) | 177-186 | |
P577 | publication date | 2006-03-01 | |
P1433 | published in | Pharmacogenomics | Q15724625 |
P1476 | title | Development of a toxicogenomics in vitro assay for the efficient characterization of compounds | |
P478 | volume | 7 |
Q38025961 | A decade of toxicogenomic research and its contribution to toxicological science |
Q27013780 | Advancing human health risk assessment: integrating recent advisory committee recommendations |
Q51467325 | Biomarker classifiers for identifying susceptible subpopulations for treatment decisions. |
Q21562369 | Comparative analysis of gene regulation by the transcription factor PPARalpha between mouse and human |
Q57477472 | Establishment of a novel safety assessment method for vaccine adjuvant development |
Q36726630 | Gene expression profiling and its practice in drug development |
Q37264550 | Identifying genetic components of drug response in mice |
Q37618225 | Mitochondrial gene profiling: translational perspectives |
Q28469153 | PPARalpha siRNA-treated expression profiles uncover the causal sufficiency network for compound-induced liver hypertrophy |
Search more.